IRLAB Therapeutics AB Stock OTC Markets
Stocks
IRLAF
SE0012675361
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 225M 23.79M 20.58M 19.22M 17.63M 33.16M 2.26B 33.68M 88.49M 1.13B 89.33M 87.37M 3.75B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 225M 23.79M 20.58M 19.22M 17.63M 33.16M 2.26B 33.68M 88.49M 1.13B 89.33M 87.37M 3.75B | EV / Sales 2026 * |
2.21x | EV / Sales 2027 * | 1.59x |
| Free-Float |
81.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
| Chairman | 68 | 2023-02-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 23.79M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.02% | +0.87% | +33.76% | +44.31% | 402.31B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.76M 9.31M 8.69M 7.98M 15M 1.02B 15.24M 40.03M 513M 40.42M 39.53M 1.7B | 142M 14.96M 12.94M 12.09M 11.09M 20.85M 1.42B 21.18M 55.66M 714M 56.19M 54.96M 2.36B |
| Net income | -32.6M -3.44M -2.98M -2.78M -2.55M -4.79M -327M -4.87M -12.8M -164M -12.92M -12.63M -542M | 33.3M 3.51M 3.04M 2.84M 2.6M 4.9M 334M 4.98M 13.07M 168M 13.19M 12.91M 554M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
- IRLAF Stock
Select your edition
All financial news and data tailored to specific country editions
